Pelvic organ prolapse (POP) is caused by defects in the pelvic floor support structure, resulting in a downward displacement of the uterus, bladder, and rectum.^[@R1]^ It is a common disease bothering all ages of women, especially older women, and greatly affects the quality of life.^[@R2]^ A population-based, cross-sectional study investigating 53,178 women in six provinces of mainland China showed that the prevalence of symptomatic POP was 9.56% (data unpublished). Current evidence suggests that both genetic and environmental factors contribute to POP.^[@R3]^ The most frequent environmental risk factors include age, body mass index, parity, and chronic increases in intra-abdominal pressure, whereas genetic risk factors include race/ethnicity, family history, Marfan syndromes or Ehlers-Danlos syndromes, and so on.^[@R2]^ The susceptibility loci of POP at the genetic level, however, remains to be elucidated since no definite conclusions have been reached so far.

The pelvic floor support system is essential in maintaining the normal anatomic position of pelvic organs. Certain risk factors can influence the structure and function of the pelvic floor connective tissues, muscles, and nerves, which can trigger POP.^[@R4],[@R5]^ Collagen fibers are the main components of the connective tissue.^[@R6],[@R7]^ Changes in the structure, content, and proportion of the collagen can lead to changes in the supporting force of the pelvic floor connective tissue, resulting in the development of POP.^[@R8]-[@R10]^

The relationship between polymorphisms in collagen type I, alpha 1 (*COL1A1*) and collagen type III, alpha 1 (*COL3A1*) and POP has been widely studied. Chen et al^[@R11]^ reported that rs1800255-AA of the *COL3A1* gene was significantly associated with POP in 84 POP cases and 147 controls in a Taiwanese population. Kluivers et al^[@R12]^ confirmed this result in an associated study in Dutch women that included 202 POP cases and 102 controls. Lince et al,^[@R13]^ however, demonstrated that the homozygous rs1800255, *COL3A1* 2209 G\>A polymorphism was not significantly associated with POP in another case-control study including 272 Dutch POP women and 82 controls. Jeon et al^[@R14]^ investigated another missense variant of *COL3A1* rs111929073 in 72 Korean women and reported that the G allele of rs111929073 was significantly increased in frequency in POP women; the odds ratio (OR) was 3.2 (95% confidence intervals \[CIs\], 1.4-7.3). Martins et al,^[@R15]^ however, demonstrated that POP was not significantly associated with rs111929073 in a Brazilian study of 107 cases and 209 controls. Another interesting candidate gene is *COL1A1*. Although Feiner et al,^[@R16]^ Cho et al,^[@R17]^ Ferrari et al,^[@R18]^ Rodrigues et al,^[@R19]^ and Skorupski et al^[@R20]^ demonstrated no significant association between *COL1A1* rs1800012 polymorphism and POP, Cartwright et al^[@R21]^ conducted a meta-analysis of data up to May 1, 2014, and suggested that the pooled effect size was significant (OR, 1.33; 95% CI, 1.02-1.73), with low inconsistency.

Collagen XVIII, alpha 1 (*COL18A1*) is a potential candidate gene that was identified by Allen-Brady et al^[@R22]^ in a genome-wide association study. rs2236479 in *COL18A1* was significantly associated with POP in 115 white women with a POP family history compared with 2,976 controls from the database. Dos Santos et al^[@R23]^ confirmed no association between the rs2236479 single-nucleotide polymorphism (SNP) in *COL18A1* and POP in 532 Brazilian women.

It is considered that POP is a common complex disease caused by genetic variants (SNPs) that are likely to occur in multiple susceptibility markers.^[@R21],[@R24]^ In addition to *COL3A1*, *COL1A1*, and *COL18A1*, our previous work also screened *COL14A1*, *COL5A1*, and *COL4A2* as possible candidate genes. Given the important role of the collagen family genes in pelvic floor connective tissues and the previous controversial findings on *COL3A1*, *COL1A1*, and *COL18A1*, we performed this study to verify the hypothesis that these genes may be associated with POP in Chinese women. In this study, we aim to conduct an analysis of *COL3A1*, *COL1A1*, and *COL18A1* genes using a target region sequencing approach with the Illumina sequencing platform in a case-control association study of Chinese women, and to determine whether any polymorphisms of these genes are associated with POP. We also examined for the first time whether any *COL14A1*, *COL5A1*, and *COL4A2* gene allele frequencies are associated with POP among Chinese women.

METHODS
=======

Study population
----------------

This was part of a case-control association study including 48 cases and 48 controls conducted at the Peking Union Medical College Hospital, Beijing, China, from October 2016 to May 2017.^[@R25]^ This study was approved by the Ethics Committee of the Peking Union Medical College Hospital. We previously recruited women, including participants diagnosed with stage III and stage IV prolapse and control participants with no prolapse (stage 0) and no prior history of prolapse surgery. All cases and controls were individuals of Chinese ancestry.

POP stages were defined by Pelvic Organ Prolapse Quantification (POP-Q) system as previously described by Bump et al.^[@R26]^ It is the most reliable grading system and widely applied in the world. Briefly, stage 0 (control women) is defined as no prolapse with each point to be at normal position. Stage I is defined when the most distal part of prolapse is more than 1 cm above the hymen. Stage II is defined when the most distal part of prolapse is less than or equal to +1 cm at the proximal end or distal end of the hymen. Stage III is identified when the most distal part of prolapse is more than +1 cm but less than +( total vaginal length − 2) cm distal to the hymen, and stage IV is defined when the most distal part of prolapse is bulging more than or equal to +(total vaginal length − 2) cm. All the measurements were taken by two trained clinical doctors.

We excluded women with known connective tissue or collagen diseases, such as Marfan syndromes or Ehlers-Danlos syndromes, gynecological malignancies, and neurological conditions, such as sclerosis or stroke. Demographic data were summarized as described in our previous study in which we matched cases and control groups by age and body mass index, and the majority of participants were postmenopausal women. Women with POP had approximately one or more deliveries and pregnancies compared to the control group.^[@R25]^

Genotyping and SNP selection
----------------------------

DNA was isolated from peripheral venous whole-blood samples. Sequencing was efficiently performed with 1 to 2 μg DNA using the Agilent Liquid Capture System (Agilent SureSelect Custom Kit; Agilent Technologies, Palo Alto, CA). Paired-end sequencing of 2 × 150 bp reads was performed at Novogene (Novogene Co., Ltd., Beijing, China) using an Illumina HiSeq 4000 platform to provide a mean coverage of more than 200× on the target regions of every sample. Thus, the capture system enabled a comprehensive evaluation of the six genes.

Based on the reference genome (UCSC hg19), the valid sequencing data were mapped by Burrows-Wheeler Aligner software^[@R27]^ to obtain the original mapping files in a binary alignment/map (BAM) format. We used Samtools^[@R28]^ and Picard (<http://broadinstitute.github.io/picard>) to sort the files and note duplicates. Samtools mpileup and bcftools were applied to the marked BAM files to call variants and identify SNPs, insertions, and deletions (indels). CoNIFER^[@R29]^ was used to identify genic copy number variants. ANNOVAR^[@R30]^ was used to annotate the variant position, variant type, conservative prediction, and other information.

We filtered the variants with a minor allele frequency greater than 5% in the 1,000 genome database (1000 Genomes Project Consortium). Single-nucleotide variants were then entered into PolyPhen-2,^[@R31]^ SIFT,^[@R32]^ MutationTaster,^[@R33]^ and CADD^[@R34]^ software for functional prediction.

Statistical analysis
--------------------

To analyze the associations of SNPs and POP, we performed Fisher exact tests for unadjusted model and logistic regression models for adjusted model using PLINK.^[@R35]^ For multivariable models in the adjusted model, we adjusted for pregnancy and delivery that were not matched between POP and control women. We presented OR and 95% CI for the altered allele, suggesting a protective effect when OR is less than 1 and a risk effect when OR is higher than 1. *P* values less than 0.05 were considered to be significant and less than 0.1 to be borderline significant. Gene structures indicating exon and intron were made by Exon-Intron Graphic Maker (<http://wormweb.org/exonintron>). The linkage disequilibrium (LD) graphic with inter-SNP *r*^2^ calculations was constructed by Haploview (Harvard Broad Institute, Boston, MA). The closer the *r*^2^ value is to 1, the greater the correlation between the two sites.

RESULTS
=======

In this case-control study, we sequenced six genes encoding the chains consisting of different types of collagen reported in previous work using an Illumina sequencing platform. We have genotyped a total of 110 SNPs in these genes (SDC). Among these, 13 SNPs with *P* values less than 0.1 were considered to be significant or borderline significant in unadjusted model and 10 SNPs with *P* values less than 0.1 in adjusted model with adjustment for delivery and pregnancy. These SNPs were further analyzed in this study (Table [1](#T1){ref-type="table"}).

In the analysis of *COL14A1*, there was a significant association between the *COL14A1* SNP rs4870723 and POP in both unadjusted model and adjusted model (OR, 0.46; 95% CI, 0.25-0.86; *P* = 0.013 and OR, 0.48; 95% CI, 0.24-0.93; *P* = 0.030, respectively), and a significant association between rs2305600 and POP in both models (OR, 0.48; 95% CI, 0.26-0.89; *P* = 0.019 and OR, 0.51; 95% CI, 0.27-0.99; *P* = 0.045). rs2305598 was significantly associated with POP in the unadjusted model (OR, 0.50; 95% CI, 0.27-0.93; *P* = 0.028). There was also a trend toward significance for the SNP rs2305603 in the unadjusted model (OR, 0.54; 95% CI, 0.29-1.01; *P* = 0.055) (Table [1](#T1){ref-type="table"}). Figure [1](#F1){ref-type="fig"}A shows a schematic of the gene structure and indicates exons and introns of the four SNP sites. rs4870723, rs2305600, and rs2305598 were in good LD with each other (*r*^2^ \> 0.9) (Fig. [1](#F1){ref-type="fig"}D). rs4870723 was a missense SNP that resulted in a substitution of asparagines for histidine located in the fibronectin type 3 domain (FN3) in COL14A1 (Fig. [2](#F2){ref-type="fig"}). rs2305600, rs2305598, and rs2305603 were synonymous SNPs that did not cause amino acid changes.

![*COL14A1*, *COL4A2*, and *COL18A1* gene structures, indication of SNPs and the linkage disequilibrium (LD) between SNPs. (**A**), (**B**), and (**C**) are *COL14A1*, *COL4A2*, and *COL18A1* gene structures, respectively, with exons presented in vertical lines. Candidate SNPs are marked by arrows and presented in different colors: exons (red) and introns (blue). (**D**), (**E**), and (**F**) are the LD graphics for *COL14A1*, *COL4A2*, and *COL18A1*, respectively, with *r*^2^ values in each box. The closer the value is to 1.0, the higher the correlation between two SNPs. Boxes without values indicate perfect LD (*r*^2^ = 1). SNP, single-nucleotide polymorphisms.](menop-27-223-g001){#F1}

![Schematic diagram indicating amino acid changes in the *COL14A1* transcript NM_021110. Protein domains for NM_021110 in *COL14A1* are shown in color boxes: collagen (orange), FN3 (fibronectin type 3 domain, blue) and vWA (collagen_alphaI-XII-like, green). The missense SNP rs4870723 is identified with a straight line. SNP, single-nucleotide polymorphism.](menop-27-223-g002){#F2}

In the analysis of *COL5A1*, there was a significant association between the SNP rs3827852, which is an intronic SNP, and POP in the unadjusted model (OR, 0.40; 95% CI, 0.18-0.86; *P* = 0.016). Regarding the gene *COL1A1*, there was a trend toward significance for the SNP rs2586488 and POP in the unadjusted model (OR, 1.73; 95% CI, 0.94-3.20; *P* = 0.082), and SNP rs2249492 and POP in the adjusted model (OR, 1.70; 95% CI, 0.93-3.10; *P* = 0.082), which were both intronic SNPs (Table [1](#T1){ref-type="table"}).

In the analysis of *COL4A2*, there was a significant association between the *COL4A2* SNPs rs76425569 (OR, 2.02; 95% CI, 1.00-4.15; *P* = 0.049), rs388222 (OR, 0.50; 95% CI, 0.24-1.00; *P* = 0.049), and rs2281968 (OR, 2.02; 95% CI, 1.00-4.15; *P* = 0.049) and POP in unadjusted model, and rs445348 (OR, 2.15; 95% CI, 1.03-4.47; *P* = 0.040) and POP in adjusted model (Table [1](#T1){ref-type="table"}). rs76425569 and rs445348 were synonymous SNPs that did not result in amino acid changes. rs388222 and rs2281968 were intronic SNPs. There was also a trend toward significance for the SNP rs74941798 in both unadjusted model and adjusted model, which is a synonymous SNP (OR, 1.93; 95% CI, 0.95-3.97; *P* = 0.070, and OR, 1.78; 95% CI, 0.92-3.46; *P* = 0.089) (Table [1](#T1){ref-type="table"}). These SNPs are indicated on the schematic in Figure [1](#F1){ref-type="fig"}B, and exons and introns are noted. rs76425569 and rs74941798 were in good LD with each other (*r*^2^ = 0.97), and rs388222 and rs2281968 were in perfect LD with each other (*r*^2^ = 1) (Fig. [1](#F1){ref-type="fig"}E).

Although there was no significant association between the *COL18A1* and *COL3A1* SNPs and POP, there was a trend toward significance for the synonymous *COL18A1* SNP rs1050351 (OR, 0.58; 95% CI, 0.31-1.07; *P* = 0.082) and two intronic *COL18A1* SNPs, rs56335679 and rs55690336, and POP in unadjusted model (for both, OR, 0.58; 95% CI, 0.31-1.07; *P* = 0.082) (Table [1](#T1){ref-type="table"}). These SNPs are marked in Figure [1](#F1){ref-type="fig"}C. All three SNPs showed perfect LD with each other (*r*^2^ = 1) (Fig. [1](#F1){ref-type="fig"}F).

DISCUSSION
==========

It is commonly considered that POP occurrence is attributed to multiple risk factors that influence the pelvic floor support system. Potential candidate genes related to connective tissue and extracellular matrix (ECM) components have attracted special interests, and many researchers have searched for polymorphisms in these genes.^[@R21],[@R24]^ In this case-control analysis of several genes encoding the chains consisting of some types of collagen, we sequenced *COL14A1*, *COL5A1*, and *COL4A2* for the first time and further confirmed the previously studied genes *COL3A1*, *COL1A1*, and *COL18A1*. As we did not match for delivery and pregnancy, which were key risk factors for POP, in case and control groups, we evaluated the association between SNPs and POP in unadjusted model and the adjusted model with adjustment for delivery and pregnancy. In the two models, we provided new evidence that in addition to *COL3A1, COL1A1,* and *COL18A1*, the genes *COL14A1*, *COL5A1*, and *COL4A2* might be potential candidates for nonfamilial POP in Chinese populations.

The main collagen types in pelvic connective tissue are collagens I and III, with very little collagen V.^[@R24]^ Collagen I is well recognized for playing a role in tissue stiffness, whereas collagen III plays a role in tissue elasticity.^[@R36]^ Previous studies have mainly focused on rs1800012 in *COL1A1*, and rs1800255 and rs111929073 in *COL3A1*. rs1800012 was also identified as the polymorphism of the transcription factor Sp1 in *COL1A1*. Five previous studies observed no association between rs1800012 and POP respectively in Israeli, Italian, Korean, Polish, and Brazilian women,^[@R16]-[@R20]^ consistent with our results in Chinese women. In addition, we found a trend toward a significant association between two SNPs, rs2586488 and rs2249492, both intronic SNPs, and POP, providing new polymorphism loci for the disease. Several studies also investigated the associations with the missense SNP rs1800255 in *COL3A1*. Chen et al^[@R11]^ and Kluivers et al^[@R12]^ showed respectively that rs1800255-AA in the *COL3A1* gene was significantly associated with POP in Taiwanese and Dutch women. In addition, the two studies contributed to the meta-analysis by Ward et al,^[@R24]^ suggesting that the AA genotype of *COL3A1* rs1800255 was significantly associated with POP compared with the GG reference genotype. However, Lince et al^[@R13]^ put forward the opposite conclusion, which was consistent with our result. Regarding the analysis of *COL3A1* rs111929073, Jeon et al^[@R14]^ reported a higher frequency of the G allele in rs111929073 in Korean women. However, Martins et al^[@R15]^ demonstrated no significance in Brazilian women. In our case-control study, we also did not observe any significant associations between *COL3A1* SNPs and POP. The reason for the diverse and controversial results may be partially due to the population frequencies of the genetic variant which may vary between different ethnic groups and may also be partially due to the different inclusion criteria (POP-Q III and IV in our study) and different detection methods (target region sequencing for our study) used in the studies.

*COL18A1*, which encodes the alpha chain of type XVIII collagen, and endostatin, which is cleaved from the C-terminal region of collagen XVIII, can act on growth factors and play a role in the structure composition of the basement membranes.^[@R37]^ We selected the *COL18A1* gene based on previous findings from the genome-wide association study by Allen-Brady et al^[@R22]^ that the rs2236479 polymorphism was significantly associated with POP. However, Giri et al^[@R38]^ and Dos Santos et al^[@R23]^ could not repeat the result. In our study, we sequenced *COL18A1* and still did not find a positive association between rs2236479 and POP. We, however, found three additional SNPs, one synonymous SNP rs1050351 and two intronic SNPs rs56335679 and rs55690336, that have borderline significant associations with POP and show that they may have potential protective effects for the disease.

We sequenced three genes, *COL14A1*, *COL5A1*, and *COL4A2*, for the first time according to our microarray data. Collagen XIV is related to fibril formation and is commonly expressed in connective tissues, such as skin, tendons, and corneas, especially in areas under high mechanical stress.^[@R39]^ This suggests that collagen XIV may influence the mechanical nature of the tissue. Evidence has indicated an effect of collagen XIV in corneal stromal compaction^[@R40]^ and endothelial maturation.^[@R41]^ Mice null for *COL14A1* showed defects in interstitial collagen network construction in the tendons and skin.^[@R42]^ Mutations of *COL14A1* have been reported in patients with punctate palmoplantar keratoderma,^[@R43]^ gastric cancer,^[@R44]^ and osteoarthritis.^[@R45]^ Given the important role of collagen XIV in ECM organization, its expression and function in the pelvic floor also need to be clarified. In our study, we found a significant association between the missense SNP rs4870723, and two synonymous SNPs rs2305600 and rs2305598, and POP, and a borderline significant association between the synonymous SNP rs2305603 and POP in Chinese women. Our study suggested that they may exhibit a protective role for POP development. rs4870723 was a missense SNP and produced a replacement of amino acid asparagines to histidine, which might have a benign effect predicted by PolyPhen-2.^[@R31]^ In addition, this amino acid change caused a slight increase in the random coil structure of protein secondary structure analyzed by GOR4.^[@R46]^ These results, however, need further validation.

Collagen V is a kind of tiny fibrillar collagen that is embedded with collagen I to form collagen fibrils.^[@R47]^ Mutations in *COL5A1* exist in approximately half of the patients with typical Ehlers-Danlos syndrome, which presents a phenotype of joint hypermobility and fragility.^[@R48]^ Collagen V is important in the organization and function of connective tissue. Our study reported an intronic SNP rs3827852 associated with POP, which should be included in future research.

COL4A2 is expressed in almost all of the basement membranes in every organ.^[@R49]^ Thus, mutations in *COL4A2* contribute to multiple disorders, including hemorrhagic stroke,^[@R50]^ cardiac abnormalities, and muscular abnormalities.^[@R51]^ No research with respect to *COL4A2* has, however, been conducted on the dysfunction of the pelvic floor. In our study, we found rs445348, rs76425569, and rs74941798, three synonymous SNPs, and rs2281968, an intronic SNP, to be risk factors of POP occurrence, whereas rs388222, an intronic SNP, may be a protective factor for POP development, indicating a potential role of COL4A2 in prolapse.

In this study, we used target region sequencing to analyze six collagen-related genes. All of the previous studies were, however, limited to only one or two SNPs in a gene. We confirmed the results of the previously reported SNPs in *COL3A1*, *COL1A1*, and *COL18A1*, and we investigated the relationship between *COL14A1*, *COL5A1*, and *COL4A2* polymorphisms and POP for the first time, resulting in several new candidate SNPs. In addition, in this candidate gene study, we investigated nonfamilial Chinese groups, which may be different in genetic background from other previous studies, as genetic variants may differ by different racial/ethnic groups. We recruited women from mainland China strictly limited to POP-Q stages III and IV, which increased the likelihood that the disease-contributing variants could be detected.

However, our study also has some limitations, the most important of which is the relatively small sample size. In our nationwide cross-sectional epidemiological survey in six populous provinces of mainland China, we demonstrated a prevalence of POP-Q stages limited to III and IV to be 2.04% (data unpublished). The strict restriction for the POP-Q stage screening also increased the difficulty for the recruitment of women within a certain period of time. Because we did not have enough power to assess the more moderate effects, more participants are needed to be enrolled in this association study for a more convincing result. Another limitation is that we only considered SNPs (minor allele frequency \>5%) in this study by target region sequencing. More genetic variants, including copy number variants, insertions, and deletions, could also be expected in the upcoming study. Finally, we detected only collagen-related genes in Han Chinese. Other candidate genes involved in ECM metabolism could be investigated in large scale in other ethnic/race groups. In summary, our results provide preliminary evidence that these polymorphisms in the genes encoding chains of different collagen types may have an association with POP, and more studies should be performed in the future.

CONCLUSIONS
===========

Collagen is an important ECM component; the alteration of collagen-related genes may be associated with the development of POP. Our study suggested several candidate SNPs that were associated with POP in the *COL3A1*, *COL1A1*, *COL18A1*, *COL14A1*, *COL5A1*, and *COL4A2* genes in a Chinese population, providing crucial information on the pathophysiology of POP.
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Allele frequencies for genes encoding chains of multiple types of collagen

                           Unadjusted   Adjusted[^a^](#TF1-1){ref-type="table-fn"}                                                                     
  ------------- ---------- ------------ -------------------------------------------- ----------- ------------------ ---------- ---------- ------------ --------
  *COL14A1*                                                                                                                                            
   rs4870723    C (0.48)   **0.013**    0.46 (0.25-0.86)                             **0.030**   0.48 (0.24-0.93)   8q24.12    Exonic     Missense     N563H
   rs2305600    C (0.49)   **0.019**    0.48 (0.26-0.89)                             **0.045**   0.51 (0.27-0.99)   8q24.12    Exonic     Synonymous   S307S
   rs2305598    C (0.49)   **0.028**    0.50 (0.27-0.93)                             0.059       0.53 (0.28-1.02)   8q24.12    Exonic     Synonymous   G204G
   rs2305603    C (0.32)   0.055        0.54 (0.29-1.01)                             0.105       0.59 (0.32-1.12)   8q24.12    Exonic     Synonymous   L794L
  *COL5A1*                                                                                                                                             
   rs3827852    G (0.67)   **0.016**    0.40 (0.18-0.86)                             0.089       0.63 (0.37-1.07)   9q34.3     Intronic   ---          ---
  *COL4A2*                                                                                                                                             
   rs445348     G (0.66)   0.237        1.48 (0.78-2.82)                             **0.040**   2.15 (1.03-4.47)   13q34      Exonic     Synonymous   P1505P
   rs76425569   A (0.33)   **0.049**    2.02 (1.00-4.15)                             0.074       1.82 (0.94-3.50)   13q34      Exonic     Synonymous   P365P
   rs388222     T (0.67)   **0.049**    0.50 (0.24-1.00)                             0.070       0.48 (0.22-1.06)   13q34      Intronic   ---          ---
   rs2281968    A (0.33)   **0.049**    2.02 (1.00-4.15)                             0.070       2.09 (0.94-4.62)   13q34      Intronic   ---          ---
   rs74941798   T (0.32)   0.070        1.93 (0.95-3.97)                             0.089       1.78 (0.92-3.46)   13q34      Exonic     Synonymous   I393I
  *COL1A1*                                                                                                                                             
   rs2586488    G (0.61)   0.082        1.73 (0.94-3.20)                             0.104       1.69 (0.90-3.19)   17q21.33   Intronic   ---          ---
   rs2249492    T (0.60)   0.111        1.65 (0.90-3.05)                             0.082       1.70 (0.93-3.10)   17q21.33   Intronic   ---          ---
  *COL18A1*                                                                                                                                            
   rs1050351    A (0.40)   0.082        0.58 (0.31-1.07)                             0.106       0.60 (0.32-1.12)   21q22.3    Exonic     Synonymous   A1326A
   rs56335679   C (0.40)   0.082        0.58 (0.31-1.07)                             0.106       0.60 (0.32-1.12)   21q22.3    Intronic   ---          ---
   rs55690336   A (0.40)   0.082        0.58 (0.31-1.07)                             0.106       0.60 (0.32-1.12)   21q22.3    Intronic   ---          ---

Significant data (*P* \< 0.05) are indicated in bold.

A, alanine; AA, amino acid; CI, confidence interval; G, glycine; H, histidine; I, isoleucine; L, leucine; N, asparagine; OR, odds ratio; P, proline; S, serine; SNP, single-nucleotide polymorphism.

^*a*^Adjusted by pregnancy and parity.
